First patients to test new pill for Tough-to-Treat cancers
Disease control
Recruiting now
This is the first study in people to test a new oral drug called FX-909. The main goals are to find a safe dose and see how well the body handles it, both alone and when combined with an existing immunotherapy drug (pembrolizumab). It is for adults with advanced solid tumors, inc…
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC